How to Manage Post-COVID-19 Vaccination Reactions among Healthcare Staff
Vaccination against COVID-19 for US healthcare personnel began on December 14, 2020; the same day, CDC hosted a webinar on how to ensure HCP health and safety during this period.
State COVID-19 Vaccine Distribution Plans, Priorities
Early COVID-19 vaccine demand will far exceed supply and so states have been refining distribution plans for months. Here is a topline review of what to expect.
SGLT2 Inhibitors Enter Vast Treatment Void for High-risk CKD Patients
Patients with chronic kidney disease have had no treatment options to slow the certain progression to renal failure. Enter SGLT2 inhibitors. A key clinical trial investigator explains.
High-dose Flu Vaccine Confers No Added Benefit for Patients with CVD
A high-dose influenza vaccine was no more effective than the standard-dose vaccine at reducing the risk of severe outcomes among patients with heart disease, NIH study finds.
CDC Reduces COVID-19 Quarantine Requirement
The CDC reduced the length of quarantine required for persons exposed to someone infected with SARS-CoV-2 from 14 days to 10 or to 7 with a negative test.
DAPA-CKD Investigator: "PCPs Should be First-line Prescribers of SGLT2 Inhibitors"
Primary care clinicians should be the first to prescribe SGLT2 inhibitors for many reasons, as explained by Prof Jonathan McMurray in this Patient Care interview.
Professor John McMurray Highlights DAPA-CKD Trial Outcomes
DAPA-CKD investigator Professor John McMurray details the trial and renal and cardiovascular outcomes for Patient Care Online.
Baloxavir Marboxil Wins FDA Label Expansion for Post-exposure Flu Prevention
The expanded indication for baloxavir marboxil is positive news as the surge in US COVID-19 cases converges with the arrival of flu season.
AstraZeneca/Oxford COVID-19 Vaccine Candidate Third to Show Promise
The AstraZeneca/Oxford vaccine candidate showed 90% efficacy in one dosing regimen; 62% in a second; and an average efficacy rate of 70%.
Once-weekly Semaglutide 2.0 mg Bests 1.0 mg Dose for A1c, Weight Reduction
Once-weekly semaglutide 2.0 mg vs 1.0 mg led to statistically significant, superior reductions in A1c and weight in type 2 diabetes patients not at goal, study finds.
Response to Dupilumab in Severe Asthma Predicted by Baseline FeNo
Increasing baseline FeNo levels were associated with reduced exacerbation and greater lung function improvement in dupilumab-vs-placebo-treated patients.
6 Essential COVID-19 Codes to Remember
COVID-19 cases are surging across the country as the US heads into holiday season. Counsel patients on staying safe and keep these billing codes very close at hand.
Moderna COVID-19 Vaccine Candidate Achieves 94.5% Efficacy in Phase 3 Trial
Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.
Omega-3s, Vitamin D Fail to Prevent Incident Atrial Fibrillation
AHA 2020: Daily supplementation with 2000 IU of vitamin D3/day and/or 840 mg omega-3 fatty acids/day did not reduce or increase risk of incident atrial fibrillation.
DAPA-CKD Trial Findings Could Transform CKD Therapy
AHA: DAPD-CKD investigator Prof John McMurray talks to Patient Care about the “revolutionary” findings he will highlight at the AHA sessions on opening day.
George Bakris, MD, Lauds FIDELIO-CKD Findings, Discusses Finerenone
Finerenone, a non-steroidal, selective MRA, has distinct advantages over current treatments for diabetic kidney disease. Dr Bakris details these and the FIDELIO results.
Black Patients Less Likely to Receive Treatment Intensification for BP Control
AHA 2020 Virtual Scientific Sessions: Nearly one-third of racial disparities in hypertension treatment may be linked to inequities in treatment intensification, study authors suggest.
Passive Smoke Exposure in Childhood May Cause Subclinical LV Dysfunction in Adults
AHA 2020 Virtual Scientific Sessions: Cumulative exposure, exposure intensity, and number of household smokers in childhood all impact adult heart function, study authors found.
Survival Associated with Healthy Lifestyle Even with Multiple Meds on Board
AHA 2020 Virtual Scientific Sessions: Healthy lifestyle habits are inversely associated with-all cause mortality, study authors found.
Tezepelumab for Severe Asthma Meets Phase 3 Primary Endpoint
The novel monoclonal antibody could bring relief to millions of persons with severe, uncontrolled asthma, including those with a low eosinophil phenotype.
PREVIEW of AHA 2020 Scientific Sessions: Late-breaking Science, Days 4 and 5
Preview days 4 and 5 of the American Heart Association 2020 live late-breaking science sessions. Decide what you need to watch and when.
AHA 2020 Scientific Sessions Preview: Late-breaking Science, Days 1, 2 and 3
What to watch during the AHA 2020 late-breaking science sessions? We break down the first 3 days of clinical trial presentations for you, here.
Pfizer COVID-19 Vaccine Candidate Achieves 90% Efficacy
Pfizer/BioNTech announced more than 90% efficacy for their vaccine against SARS-CoV-2 infection in the first interim analysis of phase 3 study.
Ticagrelor Wins Label Expansion to Reduce Risk of Recurrent Stroke, TIA
FDA approval is based on results of the phase III THALES trial, in which DAPT with ticagrelor and aspirin for 30 days reduced the rate of stroke and death by 17% vs aspirin alone.
COPD Self-management App Reduces Exacerbations, Readmissions vs Usual Care
Use of the myCOPD app after hospitalization for acute COPD exacerbation reduced subsequent exacerbations by nearly 50%, according to study authors.
CLINICAL FOCUS COLLECTION: Obesity
Obesity, a complex chronic disease in itself, underlies many of the fatal cardiac and cardiometabolic diseases of the 21st century. Find a wide collection of expert guidance in this collection.
Pharmacotherapy for Obesity Should Begin in Primary Care
Video: Obesity expert Dr Louis Aronne outlines the role of medication in obesity treatment and says primary care is absolutely the place to begin.
COVID-19 Patients with Obesity Have Lower Inflammatory Biomarkers, Study Finds
Obese patients hospitalized with COVID-19 had lower levels of inflammation biomarkers but outcomes similar to non-obese patients with elevated levels of those biomarkers.
COVID-19 Lockdown Sidelines Weight Control Effort Among Obese Youth
A longitudinal study of weight reduction in adolescents was redesigned to accommodate pandemic lockdown--and the results are very concerning.
Aspirin Reduces COVID-19 Mortality: Investigator's Insights
Dr Jonathan Chow reviews study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for use of ICU, mechanical ventilation, and of death.
